Literature DB >> 19520157

Select cyclopentenone prostaglandins trigger glutathione efflux and the role of ABCG2 transport.

Heather M Brechbuhl1, Elysia Min, Chirag Kariya, Barbara Frederick, David Raben, Brian J Day.   

Abstract

Electrophilic cyclopentenone prostaglandins (cyPGs), such as 15-deoxy-Delta(12,14)-prostaglandin J(2) (15dPGJ(2)), initiate redox-based cell signaling responses including increased intracellular glutathione (GSH) synthesis. We investigated whether cyPGs facilitated GSH efflux and if members of the ATP-binding cassette (ABC) protein family mediated the efflux. Four human cell lines were treated with 1-6 microM cyPGs for 48 h. Media and cells were harvested for GSH measurements using HPLC-EC. CyPG treatment increased extracellular GSH levels two- to threefold over controls in HN4 and C38 cells and five- to sixfold in SAEC and MDA 1586 cells and was dependent on increased GSH synthesis. Our studies show that prostaglandin D(2) and its metabolites, prostaglandin J(2) and 15dPGJ(2), specifically induce GSH efflux compared to other eicosanoids. These higher extracellular GSH levels were associated with protection from tert-butylhydroperoxide. Superarray analysis of ABC transporters suggested only ABCG2 expression had a positive relationship in the four cell types compared with extracellular GSH increases after cyPG treatment. The ABCG2 substrate Hoechst 33342 inhibited extracellular GSH increase after 15dPGJ(2) treatment. We report for the first time that ABCG2 may play a role in GSH efflux in response to cyPG treatment and may link inflammatory signaling with antioxidant adaptive responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520157      PMCID: PMC2730198          DOI: 10.1016/j.freeradbiomed.2009.06.005

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  66 in total

1.  Enhancement of the activity of doxorubicin by inhibition of glutamate transporter.

Authors:  Y Sadzuka; T Sugiyama; T Suzuki; T Sonobe
Journal:  Toxicol Lett       Date:  2001-09-15       Impact factor: 4.372

Review 2.  Differential modulation of normal and tumor cell proliferation by reactive oxygen species.

Authors:  Carole Nicco; Alexis Laurent; Christiane Chereau; Bernard Weill; Frédéric Batteux
Journal:  Biomed Pharmacother       Date:  2005-03-21       Impact factor: 6.529

Review 3.  Active efflux across the blood-brain barrier: role of the solute carrier family.

Authors:  Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  NeuroRx       Date:  2005-01

Review 4.  Eicosanoids, osteoarthritis, and crystal deposition diseases.

Authors:  Eamonn S Molloy; Geraldine M McCarthy
Journal:  Curr Opin Rheumatol       Date:  2005-05       Impact factor: 5.006

5.  Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease.

Authors:  Xibin Liang; Qian Wang; Tracey Hand; Liejun Wu; Richard M Breyer; Thomas J Montine; Katrin Andreasson
Journal:  J Neurosci       Date:  2005-11-02       Impact factor: 6.167

6.  Controlling tumor growth by modulating endogenous production of reactive oxygen species.

Authors:  Alexis Laurent; Carole Nicco; Christiane Chéreau; Claire Goulvestre; Jérôme Alexandre; Arnaud Alves; Eva Lévy; Francois Goldwasser; Yves Panis; Olivier Soubrane; Bernard Weill; Frédéric Batteux
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

7.  Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione.

Authors:  Javier Gayarre; Konstantinos Stamatakis; Marta Renedo; Dolores Pérez-Sala
Journal:  FEBS Lett       Date:  2005-10-06       Impact factor: 4.124

8.  Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury.

Authors:  Mie Mochizuki; Yukio Ishii; Ken Itoh; Takashi Iizuka; Yuko Morishima; Toru Kimura; Takumi Kiwamoto; Yosuke Matsuno; Ahamed E Hegab; Akihiro Nomura; Tohru Sakamoto; Koji Uchida; Masayuki Yamamoto; Kiyohisa Sekizawa
Journal:  Am J Respir Crit Care Med       Date:  2005-03-04       Impact factor: 21.405

9.  Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages.

Authors:  Erik S Musiek; Ling Gao; Ginger L Milne; Wei Han; M Brett Everhart; Dingzhi Wang; Michael G Backlund; Raymond N DuBois; Giuseppe Zanoni; Giovanni Vidari; Timothy S Blackwell; Jason D Morrow
Journal:  J Biol Chem       Date:  2005-08-12       Impact factor: 5.157

Review 10.  ATP-binding cassette (ABC) transporters in normal and pathological lung.

Authors:  Margaretha van der Deen; Elisabeth G E de Vries; Wim Timens; Rik J Scheper; Hetty Timmer-Bosscha; Dirkje S Postma
Journal:  Respir Res       Date:  2005-06-20
View more
  7 in total

1.  The thiocyanate analog selenocyanate is a more potent antimicrobial pro-drug that also is selectively detoxified by the host.

Authors:  Brian J Day; Preston E Bratcher; Joshua D Chandler; Matthew B Kilgore; Elysia Min; John J LiPuma; Robert J Hondal; David P Nichols
Journal:  Free Radic Biol Med       Date:  2019-11-15       Impact factor: 7.376

2.  Human ABCG2: structure, function, and its role in multidrug resistance.

Authors:  Wei Mo; Jian-Ting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2011-03-30

3.  Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ(12,14)-prostaglandin J₂-like compounds (deoxy-J₂-isoprostanes) in vivo.

Authors:  Klarissa D Hardy; Brian E Cox; Ginger L Milne; Huiyong Yin; L Jackson Roberts
Journal:  J Lipid Res       Date:  2010-10-13       Impact factor: 5.922

4.  ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity.

Authors:  Charlotte Gauthier; Csilla Ozvegy-Laczka; Gergely Szakacs; Balazs Sarkadi; Attilio Di Pietro
Journal:  Front Pharmacol       Date:  2013-11-07       Impact factor: 5.810

5.  R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice.

Authors:  Katja Schmitz; Natasja de Bruin; Philipp Bishay; Julia Männich; Annett Häussler; Christine Altmann; Nerea Ferreirós; Jörn Lötsch; Alfred Ultsch; Michael J Parnham; Gerd Geisslinger; Irmgard Tegeder
Journal:  EMBO Mol Med       Date:  2014-11       Impact factor: 12.137

6.  Kinetic Modeling of ABCG2 Transporter Heterogeneity: A Quantitative, Single-Cell Analysis of the Side Population Assay.

Authors:  Adam F Prasanphanich; Douglas E White; Margaret A Gran; Melissa L Kemp
Journal:  PLoS Comput Biol       Date:  2016-11-16       Impact factor: 4.475

Review 7.  Modulation of Mast Cell Reactivity by Lipids: The Neglected Side of Allergic Diseases.

Authors:  Philipp M Hagemann; Stephanie Nsiah-Dosu; Jennifer Elisabeth Hundt; Karin Hartmann; Zane Orinska
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.